Isolated MCA disease in patients without significant atherosclerotic risk factors a high-resolution magnetic resonance imaging study

Stroke

Volumn 46, Issue 3, 2015, Pages 697-703

  Ahn, Sung Ho ^a   Lee, Jookyung ^a   Kim, Yeon Jung ^a   Kwon, Sun U ^a   Lee, Deokhee ^a   Jung, Seung Chai ^a   Kang, Dong Wha ^a   Kim, Jong S ^a  

^a University of Ulsan   (South Korea)

Author keywords

Atherosclerosis; Dissection; Middle cerebral artery; Moyamoya disease

Indexed keywords

GADOLINIUM;

ADULT; ARTERY DISSECTION; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SOUTH KOREA; TERTIARY CARE CENTER; VASCULITIS; YOUNG ADULT; INTRACRANIAL ARTERIOSCLEROSIS; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME;

ADULT; CEREBRAL ANGIOGRAPHY; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; SMOKING; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84929267916     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008181     Document Type: Article

References (34)

1. Bang OY. Intracranial atherosclerosis: current understanding and perspectives. J Stroke. 2014;16:27-35. doi: 10.5853/jos.2014.16.1.27.
2. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
3. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, et al; WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068. doi: 10.1212/01.wnl.0000279338.18776.26.
4. Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, Boden-Albala B, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2009;28:65-71. doi: 10.1159/000219299.
5. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 2005;65:296-298. doi: 10.1212/01.wnl.0000168862.09764.9f.
6. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27:1974-1980.
7. Kim YD, Choi HY, Jung YH, Nam CM, Yang JH, Cho HJ, et al. Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis. Neuroepidemiology. 2009;32:201-207. doi: 10.1159/000195690.
8. Kim JS, Bonovich D. Research on intracranial atherosclerosis from the East and west: why are the results different? J Stroke. 2014;16:105-113. doi: 10.5853/jos.2014.16.3.105.
9. Klein IF, Lavallée PC, Touboul PJ, Schouman-Claeys E, Amarenco P. In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology. 2006;67:327-329. doi: 10.1212/01. wnl.0000225074.47396.71.
10. Ryu CW, Jahng GH, Kim EJ, Choi WS, Yang DM. High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis. 2009;27:433-442. doi: 10.1159/000209238.
11. Xu WH, Li ML, Gao S, Ni J, Zhou LX, Yao M, et al. In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis. 2010;212:507-511. doi: 10.1016/j.atherosclerosis.2010.06.035.
12. Vergouwen MD, Silver FL, Mandell DM, Mikulis DJ, Swartz RH. Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol. 2011;68:338-342. doi: 10.1001/archneurol.2011.20.
13. Degnan AJ, Gallagher G, Teng Z, Lu J, Liu Q, Gillard JH. MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease. AJNR Am J Neuroradiol. 2012;33:1427-1435. doi: 10.3174/ajnr. A2697.
14. Kim SM, Ryu CW, Jahng GH, Kim EJ, Choi WS. Two different morphologies of chronic unilateral middle cerebral artery occlusion: evaluation using high-resolution MRI. J Neuroimaging. 2014;24:460-466. doi: 10.1111/jon. 12009.
15. Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, et al. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology. 2009;72:627-634. doi: 10.1212/01. wnl.0000342470.69739.b3.
16. Li ML, Xu WH, Song L, Feng F, You H, Ni J, et al. Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis. 2009;204:447-452. doi: 10.1016/j. atherosclerosis.2008.10.019.
17. Kim YJ, Lee DH, Kwon JY, Kang DW, Suh DC, Kim JS, et al. High resolution MRI difference between moyamoya disease and intracranial atherosclerosis. Eur J Neurol. 2013;20:1311-1318. doi: 10.1111/ene.12202.
18. Fiebach J, Brandt T, Knauth M, Jansen O. [MRI with fat suppression in the visualization of wall hematoma in spontaneous dissection of the internal carotid artery]. Rofo. 1999;171:290-293. doi: 10.1055/s-1999-257.
19. Love BB, Biller J, Jones MP, Adams HP Jr, Bruno A. Cigarette smoking. A risk factor for cerebral infarction in young adults. Arch Neurol. 1990;47:693-698.
20. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis. 2006;22:109-115. doi: 10.1159/000093238.
21. Goyal MS, Hallemeier CL, Zipfel GJ, Rich KM, Grubb RL Jr, Chicoine MR, et al. Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals. Neurosurgery. 2010;67:278-285. doi: 10.1227/01. NEU.0000371977.55753. DE.
22. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(suppl 2):S1-S5.
23. Kim JS, Nah HW, Park SM, Kim SK, Cho KH, Lee J, et al. Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43:3313-3318. doi: 10.1161/STROKEAHA.112.658500.
24. Kim YD, Choi HY, Cho HJ, Cha MJ, Nam CM, Han SW, et al. Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients. Yonsei Med J. 2010;51:318-325. doi: 10.3349/ymj.2010.51.3.318.
25. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1, 000 consecutive patients with first stroke. Stroke. 1988;19:1083-1092.
26. Schievink WI, Mokri B, O'Fallon WM. Recurrent spontaneous cervicalartery dissection. N Engl J Med. 1994;330:393-397. doi: 10.1056/NEJM199402103300604.
27. Bachmann R, Nassenstein I, Kooijman H, Dittrich R, Kugel H, Niederstadt T, et al. Spontaneous acute dissection of the internal carotid artery: high-resolution magnetic resonance imaging at 3.0 tesla with a dedicated surface coil. Invest Radiol. 2006;41:105-111.
28. Gao PH, Yang L, Wang G, Guo L, Liu X, Zhao B. Symptomatic unruptured isolated middle cerebral artery dissection: clinical and magnetic resonance imaging features [published online ahead of print September 6, 2014]. Clin Neuroradiol. http://link.springer.com/article/10.1007%2Fs00062-014-0337-z. Accessed August 13, 2014
29. Lin CH, Jeng JS, Yip PK. Middle cerebral artery dissections: differences between isolated and extended dissections of internal carotid artery. J Neurol Sci. 2005;235:37-44. doi: 10.1016/j.jns.2005.03.047.
30. Obusez EC, Hui F, Hajj-Ali RA, Cerejo R, Calabrese LH, Hammad T, et al. High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol. 2014;35:1527-1532. doi: 10.3174/ajnr. A3909.
31. Yang WQ, Huang B, Liu XT, Liu HJ, Li PJ, Zhu WZ. Reproducibility of high-resolution MRI for the middle cerebral artery plaque at 3T. Eur J Radiol. 2014;83:e49-e55. doi: 10.1016/j.ejrad.2013.10.003.
32. Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, et al. High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke. 2014;45:2457-2460. doi: 10.1161/STROKEAHA.114.004761.
33. Hauenstein C, Reinhard M, Geiger J, Markl M, Hetzel A, Treszl A, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51:1999-2003. doi: 10.1093/rheumatology/kes153.
34. Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16:65-72. doi: 10.5853/jos.2014.16.2.65.